Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress

NCT02742532 is registered in ClinicalTrials.gov with Jennifer Mitchell as lead sponsor.

NCT NCT02742532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02742532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
Lead sponsor
Jennifer Mitchell
Phase
Phase 2
Overall status
Completed
Start date
April 20, 2017
Completion date
July 1, 2019
Enrollment
63 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, anxiety disorders, stress disorders, post-traumatic, substance use disorders